申请人:Merck Serono SA
公开号:US08202856B2
公开(公告)日:2012-06-19
The invention relates to compounds of formula I:
wherein R1, R2,Ra, Rb, X have the meanings given in claim 16. The compounds are useful e.g. in the treatment of autoimmune disorders, such as multiple sclerosis.
本发明涉及式I的化合物:其中R1、R2、Ra、Rb、X具有索权16所给出的含义。这些化合物可用于治疗自身免疫性疾病,如多发性硬化症。